share_log

Stifel Initiates Coverage On ClearPoint Neuro With Buy Rating, Announces Price Target of $8

Stifel Initiates Coverage On ClearPoint Neuro With Buy Rating, Announces Price Target of $8

Stifel 以買入評級開始對 ClearPoint Neuro 進行報道,宣佈目標股價爲 8 美元
Benzinga ·  2023/10/24 04:46

Stifel analyst Mathew Blackman initiates coverage on ClearPoint Neuro (NASDAQ:CLPT) with a Buy rating and announces Price Target of $8.

Stifel分析師馬修·布萊克曼對ClearPoint Neuro(納斯達克:CLPT)的評級為買入,並宣佈目標價為8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論